Historic Time in Treatment of Rare Disease as Promising Drugs Reach Phase 3 Trials
Site Search
Showing 1 - 10 of 22 results
Press Release
|
|
2 min read
Press Release
|
|
3 min read
Legislation to Help Speed Research for Cystic Fibrosis and Other Rare Diseases
Press Release
|
|
4 min read
Bill Would Remove Financial Penalties for Participating in Research Studies
Press Release
|
|
4 min read
Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model
Press Release
|
|
5 min read
This is an exciting time in cystic fibrosis clinical research. Not only are there several clinical trials of therapies to treat the underlying cause of CF, but there are also many trials to treat key symptoms of CF and improve quality of life. These include studies of antibiotics and anti-inflammatories to treat lung infections and inflammation, as well as treatments to improve nutrition and digestion.
CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process
Press Release
|
|
5 min read
Press Release
|
|
3 min read
CFF-Championed Bill Eliminates Barriers to Participation in Clinical Trials for People with CF and other Rare Diseases
Press Release
|
|
5 min read
Today, the Cystic Fibrosis Foundation announced a new award of up to $2 million to Eloxx Pharmaceuticals Inc. to support the global Phase 2 clinical program of ELX-02, a potential therapy to treat people with cystic fibrosis who have nonsense mutations.
Press Release
|
|
4 min read